Intrinsiqq
American Shared Hospital Services logo

American Shared Hospital Services Quality Score

AMS

⊜ Compare
Quality30

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
0/100
-4.9x

Negative earnings, no valuation support

Cash Flow Multiple
100/100
2.3x

Under 20x cash flow, well covered

Revenue Growth
100/100
11.4%

Above 10% CAGR, strong compounder

Cash Flow Growth
0/100
-15.2%

Below 2%, essentially flat

Business Quality & Capital Allocation

Share Dilution
0/100
9.0%

Heavy dilution above 5%

Margin Trend
0/100
-24.1pp

Contracted >2pp, margin pressure

Capital Structure
0/100
$30M

Net debt/FCF of 8.6x, high leverage

2022
$12.0M
$14.0M
2023
$14.0M
$13.0M
2024
$11.0M
$22.0M
2025
$3.00M
$22.0M
TTM
$7.00M
$37.0M
CashDebt
Return on Capital
0/100
-5.3%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

American Shared Hospital Services (AMS) quality: score, margins and returns

American Shared Hospital Services (AMS) scores 30/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 7 metrics each scored 0 to 100, on -11.8% operating margins and -5.3% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is American Shared Hospital Services (AMS) a high-quality business?+

American Shared Hospital Services scores 30 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a -11.8% operating margin and a -5.3% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does American Shared Hospital Services's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from AMS's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where American Shared Hospital Services scores well and where it falls behind.

What is American Shared Hospital Services's return on invested capital (ROIC)?+

American Shared Hospital Services earns about -5.3% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to AMS's margins and growth on this scorecard to judge durability.

How profitable is American Shared Hospital Services?+

American Shared Hospital Services runs an operating margin of about -11.8% and a net margin of about -4.2%. Revenue has grown at roughly 9.5% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 11 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 28 Sept 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Services-Medical Laboratories · Pick stocks to compare with AMS

CompareIntrinsic value
CFORCapForce Inc.
$6.91-29.18%50
PMDIPsychemedics Corp.
$2.49+0.00%39
BGLCBionexus Gene Lab Corp.
$0.94-1.05%20
PSNLPersonalis Inc.
$15.79+0.25%33
BNRBurning Rock Biotech Ltd
$12.83+17.28%25
XGNExagen Inc.
$8.51+2.04%30
BDSXBiodesix Inc.
$21.49+2.09%30
GRALGrail, Inc.
$143.79+3.12%40

Spot a number that looks wrong? Check it in AMS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AMS

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.